Results 251 to 260 of about 68,638 (278)
Some of the next articles are maybe not open access.

Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma

Virchows Archiv, 2020
Only few studies examined the prognostic effect of tumor budding in esophageal adenocarcinomas so far. However, different quantification approaches were used, so results cannot be directly compared. Recently, the International Tumor Budding Consensus Conference (ITBCC) published consensus criteria for the evaluation of tumor budding in colorectal ...
Philipp Lohneis   +7 more
openaire   +2 more sources

The phenomenon of tumor budding in gastric cancer

Russian Journal of Archive of Pathology
Gastric cancer remains the fifth most common malignant neoplasm in the world and ranks fifth among the causes associated with cancer. The TNM system remains the gold standard for predictive stratification of patients with gastric cancer, but the search for new sensitive, specific and reproducible biomarkers to develop a personalized approach to the ...
T.M. Polushkina   +2 more
openaire   +2 more sources

Tumor Budding: Prognostic Value in Muscle-invasive Bladder Cancer

Urology, 2019
To assess if "tumor budding" (TB) behaves as a poor prognostic factor in muscle-invasive bladder carcinoma (MIBC). TB is the presence of tumor cells isolated or in small groups of fewer than 5 cells located at the tumor invasion front.Retrospective study of 106 patients with MIBC who underwent radical cystectomy.
Laura, Lorenzo Soriano   +6 more
openaire   +2 more sources

Tumor budding in colorectal cancer—ready for diagnostic practice?

Human Pathology, 2016
Tumor budding is an important additional prognostic factor for patients with colorectal cancer (CRC). Defined as the presence of single tumor cells or small clusters of up to 5 cells in the tumor stroma, tumor budding has been likened to an epithelial-mesenchymal transition.
Koelzer, Viktor H   +2 more
openaire   +3 more sources

Brain and other central nervous system tumor statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Kimberly D Miller   +2 more
exaly  

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino   +2 more
exaly  

Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions

Ca-A Cancer Journal for Clinicians, 2021
Michael L Cheng   +2 more
exaly  

Home - About - Disclaimer - Privacy